Down syndrome candidate region 1 increases the stability of the IκBα protein -: Implications for its anti-inflammatory effects
Down syndrome candidate region 1 increases the stability of the IκBα protein -: Implications for its anti-inflammatory effects
复制标题
DOI:
10.1074/jbc.m604659200
复制
发表时间:
2006-12-22
影响因子:
4.8
通讯作者:
Cho, Young-Jin
中科院分区:
文献类型:
--
作者:
Kim, Young Sun;Cho, Kyung-Ok;Cho, Young-Jin
Down syndrome candidate region 1 (DSCR1), an endogenous inhibitor of calcineurin, inhibits the expression of genes involved in the inflammatory response. To elucidate the molecular basis of these anti-inflammatory effects, we analyzed the role of DSCR1 in the regulation of NF-kappa B transactivation using glioblastoma cells stably transfected with DSCR1.4 or its truncation mutants (DSCR1.4-(1-133) and DSCR1.4-(134-197)). Overexpression of DSCR1.4 significantly attenuated the induction of cyclooxygenase-2 (COX-2) expression by phorbol 12-myristate 13-acetate (PMA) via a calcineurin-independent mechanism. Experiments using inhibitors of the signaling molecules for NF-kappa B activation showed that NF-kappa B is responsible for the induction of COX-2. Full-length and truncated DSCR1.4 decreased the steady-state activity of NF-kappa B as well as PMA-induced activation of NF-kappa B, which correlated with attenuation of COX-2 induction. DSCR1.4 did not affect the PMA-stimulated phosphorylation or degradation kinetics of I kappa B alpha; however, DSCR1.4 significantly decreased the basal turnover rate of I kappa B alpha and consequently up-regulated its steady-state level. In the same context, knockdown of endogenous DSCR1.4 increased the turnover rate of I kappa B alpha as well as COX-2 induction. These results suggest that DSCR1 attenuates NF-kappa B-mediated transcriptional activation by stabilizing its inhibitory protein, I kappa B alpha.